Cabaletta Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cabaletta Bio, Inc. (CABA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents163.96193.2481.61122.22108.66136.20
Short-Term Investments0.0048.0124.940.007.230.00
Cash & Short-Term Investments163.96241.25106.55122.22108.66136.20
Accounts Receivable0.000.000.000.000.000.00
Inventory0.000.000.000.000.000.00
Other Current Assets2.713.242.292.323.020.00
Total Current Assets166.68244.49108.83124.54113.54140.55
Non-Current Assets
Property, Plant & Equipment (Net)16.087.457.571.440.890.82
Other Non-Current Assets2.291.710.570.360.300.10
Total Non-Current Assets18.379.168.131.801.190.92
Total Assets185.05253.65116.97126.34114.72141.47
Current Liabilities
Accounts Payable4.924.552.462.331.240.92
Short-Term Debt9.980.000.000.000.000.00
Accrued Liabilities3.837.854.815.993.900.00
Other Current Liabilities0.040.040.046.053.942.23
Total Current Liabilities27.0915.999.498.385.183.15
Non-Current Liabilities
Long-Term Debt5.631.462.960.000.000.00
Other Non-Current Liabilities0.000.000.000.000.000.00
Total Non-Current Liabilities5.631.462.960.000.000.00
Total Liabilities32.7117.4512.458.385.183.15
Stockholders' Equity
Common Stock0.000.000.000.000.000.00
Retained Earnings-349.10-233.24-165.56-112.59-66.29-32.96
Accumulated Other Comprehensive Income0.000.04-0.050.000.010.00
Additional Paid-in Capital501.44469.40270.13230.54175.84171.28
Shares Outstanding50.7446.3829.4528.930.000.00
Total Stockholders' Equity152.34236.20104.52117.96109.54138.32
Total Liabilities & Equity185.05253.65116.97126.34114.72141.47